Testing cytokine levels in cerebrospinal fluid (CSF) may rapidly differentiate brain infections from other central nervous system (CNS) diseases, new research suggests. "We have many tests for making ...
Our retrospective cross-sectional study included children 18 years of age or younger who underwent lumbar puncture for clinical indications in the emergency department of a single tertiary-care ...
IDH mutation status impact on in vivo hypoxia biomarkers expression: New insights from a clinical, nuclear imaging, and immunohistochemical study in 34 patients with glioma. Background: Cerebrospinal ...
Protein appears in nearly all body tissues, along with your enzymes, blood, and cerebrospinal fluid (CSF). Healthy CSF has a low amount of protein. If you show symptoms of an infection or nervous ...
Diagnostic testing of CSF for surrogate disease markers (i.e., 14-3-3 and total tau) assumes that the patient had a history of acute dementia but did not have several conditions that might compromise ...
When a disease-modifying therapy becomes available, early diagnosis of Alzheimer's disease and diagnostic testing will be enthusiastically embraced by patients and neurologists. At that point, the ...
The first generation of CSF biomarkers for Alzheimer disease comprises those that measure the component proteins of the disease’s signature pathologic lesions. They have been explored for almost 15 ...
Blood tests for Alzheimer’s disease are now so accurate that a positive result, on its own, is reason enough for people who are suspected of having AD to start immunotherapy. So proffered Suzanne ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results